Aflac/$AFL

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Aflac

Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.

Ticker

$AFL
Sector

Primary listing

NYSE

Employees

12,694

Aflac Metrics

BasicAdvanced
$60B
25.36
$4.43
0.84
$2.24
2.07%

What the Analysts think about Aflac

Analyst ratings (Buy, Hold, Sell) for Aflac stock.

Bulls say / Bears say

Aflac reported adjusted Q2 earnings per share of $1.78, beating Wall Street expectations of $1.70 and showing earnings strength (Reuters)
The U.S. segment posted 3.4% growth in net earned premiums to $1.5 billion in Q2, reflecting solid domestic demand for supplemental insurance (Reuters)
Aflac’s board declared a Q3 dividend of $0.58 per share, continuing its longstanding record of annual dividend increases and returning capital to shareholders (Reuters)
Total Q2 revenue fell 17.6% year-over-year to $4.2 billion, missing analysts’ forecast of $4.33 billion, showing pressure on the top line (Reuters)
The company posted net investment losses of $421 million in Q2, compared to gains of $696 million a year earlier, weighing on both profitability and adjusted earnings (Reuters)
Aflac reported a cybersecurity breach on its U.S. network on June 12 that may have exposed customers’ personal data, posing considerable regulatory and reputational risks (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 6 Oct 2025.

Aflac Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Aflac Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $AFL

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs